Shang-Hsuan Peng Bang-Bin Chen Ting-Chun Kuo Jen-Chieh Lee Shih-Hung Yang
10.3389/fimmu.2022.1077840
Front Immunol
2022 Dec 13;13:1077840.
case report maintenance therapy mismatch repair nivolumab pancreatic ductal adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36582237/
Adenocarcinoma / drug therapy Adenocarcinoma / genetics Adenocarcinoma / pathology Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / genetics
Adenocarcinoma / drug therapy Adenocarcinoma / genetics Adenocarcinoma / pathology Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / genetics Case Reports DNA-Binding Proteins / genetics Female Germ-Line Mutation Humans Leucovorin / therapeutic use Middle Aged Nivolumab / therapeutic use Nivolumab Leucovorin DNA-Binding Proteins Pancreatic Carcinoma
PMC9792834
36582237
Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case report
2022